Staff

TOP 5 publications:

1. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents.Pharmacol Ther. 2022 230:107940. Epub 2021 Jun 23.
2. Mechler K, Mountford WK, Hoffmann GF, Ries M. Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency.Genet Med. 2015 17(12):965-70. Epub 2015 Mar 12.
3. Purper-Ouakil D, Blasco-Fontecilla H, Ros T, Acquaviva E, Banaschewski T, Baumeister S, Bousquet E, Bussalb A, Delhaye M, Delorme R, Drechsler R, Goujon A, Häge A, Kaiser A, Mayaud L, Mechler K, Menache C, Revol O, Tagwerker F, Walitza S, Werling AM, Bioulac S, Brandeis D. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.J Child Psychol Psychiatry. 2022 63(2):187-198. Epub 2021 Jun 24.
4. Häge A, Krämer R, Dunlap M, Mechler K, Müller-Vahl KR, Nagy P. Emerging therapeutic approaches for Tourette syndrome and other tic disorders - a systematic review of current clinical trials.Eur Child Adolesc Psychiatry. 2025 34(6):1719-1729. Epub 2024 Dec 23.
5. Hinderhofer K, Mechler K, Hoffmann GF, Lampert A, Mountford WK, Ries M. Critical appraisal of genotype assessment in molybdenum cofactor deficiency.J Inherit Metab Dis. 2017 40(6):801-811. Epub 2017 Sep 12.